Continuous intravenous dihydroergotamine in the treatment of intractable headache

Headache

Volumn 37, Issue 3, 1997, Pages 129-136

  Ford, Robert G ^a   Ford, Kay T ^a  

^a Ford Headache Clinic   (United States)

Author keywords

chronic daily headache; continuous IV DHE; dihydroergotamine mesylate (DHE); headache free; intravenous infusion pump; repetitive IV DHE

Indexed keywords

ATROPINE PLUS DIPHENOXYLATE; BENZATROPINE MESILATE; BENZODIAZEPINE DERIVATIVE; DIHYDROERGOTAMINE MESILATE; ERGOTAMINE DERIVATIVE; METOCLOPRAMIDE; PROCHLORPERAZINE;

ADULT; AGED; AKATHISIA; ARTICLE; CLINICAL TRIAL; CONTINUOUS INFUSION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DRUG EFFICACY; DRUG SAFETY; DYSTONIA; FEMALE; HEADACHE; HUMAN; INTRACTABLE PAIN; INTRAVENOUS DRUG ADMINISTRATION; LEG CRAMP; MAJOR CLINICAL STUDY; MALE; NAUSEA; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; VOMITING;

ADOLESCENT; ADULT; AGED; ANALGESICS, NON-NARCOTIC; DIHYDROERGOTAMINE; DRUG STABILITY; FEMALE; HEADACHE; HUMANS; INFUSIONS, INTRAVENOUS; MALE; MIDDLE AGED; NAUSEA; PAIN, INTRACTABLE;

EID: 0031002573     PISSN: 00178748     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1526-4610.1997.3703129.x     Document Type: Article

References (15)

1. Raskin NH. Repetitive intravenous dihydroergotamine as therapy for intractable migraine. Neurology. 1986;36:995-997.
2. Silberstein SD, Schulman EA, Hopkins MM. Repetitive intravenous DHE in the treatment of refractory headache. Headache. 1990;30:334-339.
3. Saper JR. Chronic headache syndromes. Neurol Clin. 1989;7:387-412.
4. Saper JR, Silberstein SD, Gordon CD, Hamel RL. Medications used in the pharmacotherapy of headache. In: Pine JW, ed. Handbook of Headache Management. Baltimore: Williams and Wilkins; 1993:44-45.
5. Schulman EA, Silberstein SD. Symptomatic and prophylactic treatment of migraine and tension-type headache. Neurology. 1992;42(suppl 2):16-21.
6. Horton BT, Peters GA, Blumenthal LS. A new product in the treatment of migraine: a preliminary report. Proc Staff Meet Mayo Clin. 1945;20:241-248.
7. Friedman MD, Wilson EJ. Migraine: its treatment with dihydroergotamine (D.H.E. 45). Ohio State Med J. 1947;43:934-938.
8. Callaham M, Raskin N. A controlled study of dihydroergotamine in the treatment of acute migraine headache. Headache. 1986;26:168-171.
9. Mathew NT, Stubits E, Nigam MP. Transformation of episodic migraine into daily headache: analysis of factors. Headache. 1982;22:66-68.
10. Kudrow L. Paradoxical effects of frequent analgesic use. Adv Neurol. 1982;33:335-341.
11. Rapoport AM. Analgesic rebound headache. Headache. 1988;28:662-665.
12. Maurer G, Frick W. Elucidation of the structure and receptor binding studies of the major primary, metabolite of dihydroergotamine in man. Eur J Clin Pharmacol. 1984;26:463-470.
13. Aellig WH. Investigation of the venoconstrictor effect of 8'hydroxy-dihydroergotamine, the main metabolite of dihydroergotamine, in man. Eur J Clin Pharmacol. 1984;26:239-242.
14. Muller-Schweinitzer E. Pharmacological actions of the main metabolites of dihydroergotamine. Eur J Clin Pharmacol. 1984;26:699-705.
15. Aellig WH, Rosenthaler J. Venoconstrictor effects of dihydroergotamine after intranasal and intramuscular administration. Eur J Clin Pharmacol. 1986;30:581-584.